In a moment...

XEINA DRUGS

The Licensing Specialists

XEINA DRUGS is a young dynamic firm specializing in the sourcing, representation and marketing of pharmaceutical and allied products.

Xeina Drugs aspires to make unique finished dosage forms accessible to the emerging markets

Our core competency lies in licensing of rare and specialized, difficult to manufacture products in the emerging markets.


Over the years, XEINA DRUGS has developed strong relations with customers and manufacturers alike making it the partner of choice for major pharmaceutical companies wishing to expand their footprint across the emerging markets. Our strategic sourcing team has worked with multiple pharmaceutical companies, and organizations across the industrial spectrum, to aid in their strategy development, portfolio identification and strategic sourcing efforts.



Leveraging Trust
to forge
powerful partnerships
- RARE MOLECULES
- FIRST ENTRY GENERICS
- EMERGING MARKETS
Xeina features in the Top 10 women startup companies of 2020

Xeina Drugs, since its inception in 2017, has been focused on creating a niche for itself by bringing in specialized products from certified suppliers and offering services to become a partner of choice to pharmaceutical companies.

Over the years, Xeina has faced lot of challenges but the zeal to provide access to quality medicines has not dampened and we have tried to provide unique solutions to overcome these challenges.

Our efforts have been recognized by CEO Insights, a Global Magazine, which has featured our CEO Ms. Rashmi Kwatra entailing her journey and the vision what Xeina holds for future.


View Article

XEINA BUSINESS UPDATES

Establishing Overseas: Xeina Drugs OU has been incorporated in Estonia on 24th September 2020.
Xeina Drugs is pleased to announce to its partners that we have established a European subsidiary which gives us better access to the European Market.
This subsidiary will focus on bringing new products in specialized therapies and expand our base within Europe.


More about Xeina Drugs... View Corporate Profile